May 13, 2021
LuMind IDSC’s Chief Scientific Officer, James Hendrix, and a team of dedicated researchers and clinicians have published a key manuscript from the Down Syndrome Clinical Trial Network (DS-CTN) using early data from the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) Study. This cross-curricular, multi-institutional effort is an important step in preparing the Down syndrome community, and those who research them, for clinical trial readiness.JTNDY2VudGVyJTNFJTVCcGRmLWVtYmVkZGVyJTIwdXJsJTNEJTIyaHR0cHMlM0ElMkYlMkZsdW1pbmRpZHNjLm9yZyUyRndwLWNvbnRlbnQlMkZ1cGxvYWRzJTJGMjAyMiUyRjA5JTJGQ3Jvc3MtU2VjdGlvbmFsLUV4cGxvcmF0aW9uLW9mLVBsYXNtYS1CaW9tYXJrZXJzLW9mLUFsemhlaW1lcnMtRGlzZWFzZS5wZGYlMjIlMjBoZWlnaHIlM0QlMjI2MDBweCUyMiUyMHdpZHRoJTNEJTIyNzAwJTIyJTVEJTNDJTJGY2VudGVyJTNF[nectar_btn size=”large” open_new_tab=”true” button_style=”regular” button_color_2=”Accent-Color” icon_family=”none” text=”Download Here” url=”https://old.lumindidsc.org/wp-content/uploads/2022/09/Cross-Sectional-Exploration-of-Plasma-Biomarkers-of-Alzheimers-Disease.pdf”][/vc_column][/vc_row]